Moderna (MRNA) Announces Proposed $1.25 Billion Public Offering of Shares of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
Go back to Moderna (MRNA) Announces Proposed $1.25 Billion Public Offering of Shares of Common Stock
May 18, 2020 4:18 PM EDT
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it has commenced an underwritten public offering of $1.25 billion in shares of common stock. In addition, Moderna expects to grant the underwriters a 30-day option to purchase up to an additional $187.5 million in shares of common stock in connection with the public offering. All shares of common stock will be offered by Moderna.
Moderna expects... More
May 18, 2020 7:30 AM EDT
After two doses all participants evaluated to date across the 25 µg and 100 µg dose cohorts seroconverted with binding antibody levels at or above levels seen in convalescent sera
mRNA-1273 elicited neutralizing antibody titer levels in all eight initial participants across the 25 µg and 100 µg dose cohorts, reaching or exceeding neutralizing antibody titers generally seen in convalescent sera
mRNA-1273 was generally safe and well tolerated
mRNA-1273 provided full protection against viral replication in the lungs in a mouse challenge... More
